moatshark My

All holdings

Tenet Healthcare

THC

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding
2
In their latest 13F (Q3 2026)
See who
Value held
$2.2m
Combined value at quarter end
Last quarter
1 bought
0 sold or trimmed
Price at Q2 ’26 end
$187.08
-0.9% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

+24.9%Q3 ’24
-24.0%Q4 ’24
+6.6%Q1 ’25
+30.9%Q2 ’25
+15.4%Q3 ’25
-2.1%Q4 ’25
-5.0%Q1 ’26
-0.9%Q2 ’26
Q3 ’24: +24.9%; Q4 ’24: -24.0%; Q1 ’25: +6.6%; Q2 ’25: +30.9%; Q3 ’25: +15.4%; Q4 ’25: -2.1%; Q1 ’26: -5.0%; Q2 ’26: -0.9%

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

3Q4 ’23
3Q1 ’24
3Q2 ’24
3Q3 ’24
2Q4 ’24
2Q1 ’25
2Q2 ’25
2Q3 ’25
2Q4 ’25
2Q1 ’26
2Q2 ’26
0Q3 ’26
Q4 ’23: 3; Q1 ’24: 3; Q2 ’24: 3; Q3 ’24: 3; Q4 ’24: 2; Q1 ’25: 2; Q2 ’25: 2; Q3 ’25: 2; Q4 ’25: 2; Q1 ’26: 2; Q2 ’26: 2; Q3 ’26: 0

Counts the managers on this site whose 13F for that quarter includes Tenet Healthcare.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding Tenet Healthcare
First Eagle Investment Management0.0%$1.7m$1.7mAdded +69%18 qtrs
Harris Associates (Oakmark)0.0%$449k$449kUnchanged53 qtrs

Download the holders: CSV · JSON · Markdown

Directors buying and selling

Open-market trades by directors, officers and 10% holders over the last 12 months. How this works
From their Form 4 filings with the SEC. Grants, option exercises and shares sold to pay tax are left out.
Insider purchases and sales of Tenet Healthcare
Bought or soldFiling
14 Sep 2026Kerrey J RobertDirector▼ Sold5,483$263.04$1.4mForm 4
14 Sep 2026Kerrey J RobertDirector▼ Sold4,025$264.10$1.1mForm 4
14 Sep 2026Kerrey J RobertDirector▼ Sold2,502$264.62$662kForm 4
10 Sep 2026Mark Richard JDirector▼ Sold10,000$263.42$2.6mForm 4
2 Sep 2026West NadjaDirector▼ Sold1,152$258.80$298kForm 4
31 Aug 2026Foo Lisa YEVP, Chief Operating Officer▼ Sold24,000$266.32$6.4mForm 4
25 Aug 2026Sutaria SaumyaCEO▼ Sold24,881$274.10$6.8mForm 4
25 Aug 2026Sutaria SaumyaCEO▼ Sold17,220$273.34$4.7mForm 4
25 Aug 2026Sutaria SaumyaCEO▼ Sold7,899$275.26$2.2mForm 4
24 Aug 2026Sutaria SaumyaCEO▼ Sold36,656$278.90$10.2mForm 4
24 Aug 2026Sutaria SaumyaCEO▼ Sold13,344$278.17$3.7mForm 4
24 Aug 2026Haney Cecil DDirector▼ Sold1,300$278.03$361kForm 4
7 Aug 2026Romo TammyDirector▼ Sold2,500$260.83$652kForm 4
6 Aug 2026Romo TammyDirector▼ Sold4,922$264.15$1.3mForm 4
5 Aug 2026Blunt RoyDirector▼ Sold600$262.68$158kForm 4
29 Jul 2026Foo Lisa YEVP, Chief Operating Officer▼ Sold10,000$258.03$2.6mForm 4
27 Jul 2026Arbour Paola MEVP, Chief Information Officer▼ Sold10,878$243.90$2.7mForm 4
27 Jul 2026Bierman James LDirector▼ Sold5,000$244.96$1.2mForm 4
27 Jul 2026Lynch Christopher S.Director▼ Sold3,837$243.44$934kForm 4

About the company

Sector
Health care · Services-General Medical & Surgical Hospitals, Nec
Incorporated in
Nevada
Financial year ends
31 December
Shares outstanding
81m at 24 Jul 2026
SEC filings
Annual reports and other filings on EDGAR

Revenue and profit

$21bn2016
$21bn2017
$18bn2018
$18bn2019
$18bn2020
$19bn2021
$19bn2022
$21bn2023
$21bn2024
$21bn2025
2016: $21bn; 2017: $21bn; 2018: $18bn; 2019: $18bn; 2020: $18bn; 2021: $19bn; 2022: $19bn; 2023: $21bn; 2024: $21bn; 2025: $21bn
Tenet Healthcare revenue and net income by year
YearRevenueNet income
2025$21bn$2.4bn
2024$21bn$4.1bn
2023$21bn$1.3bn
2022$19bn$1.0bn
2021$19bn$1.5bn
2020$18bn–
2019$18bn–
2018$18bn–
2017$21bn–
2016$21bn–

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.